Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Allovir Inc (NQ: ALVR ) 0.7696 +0.0150 (+1.99%) Streaming Delayed Price Updated: 1:27 PM EDT, Aug 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Allovir Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Why Root Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket June 22, 2023 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 100.8% to $2.65 in pre-market trading after dropping 43% on Wednesday. Via Benzinga AlloVir, DigitalOcean And Other Big Stocks Moving Lower In Thursday's Pre-Market Session June 22, 2023 U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. AlloVir, Inc. (NASDAQ: ALVR) shares dipped 24.1% to $3.74 in pre-market... Via Benzinga AlloVir Announces Pricing of Public Offering of Common Stock June 21, 2023 From AlloVir, Inc. Via Business Wire Why AlloVir Stock Is Tumbling After Hours June 21, 2023 AlloVir Inc (NASDAQ: ALVR) shares are trading lower in Wednesday's after-hours session after the company proposed a public offering. Via Benzinga AlloVir: Q1 Earnings Insights May 04, 2023 Via Benzinga AlloVir Announces Proposed Public Offering of Common Stock June 21, 2023 From AlloVir, Inc. Via Business Wire Why Shares of AlloVir Jumped This Week June 09, 2023 The company's lead therapy fared well in preventing infections for kidney transplant patients. Via The Motley Fool 12 Health Care Stocks Moving In Tuesday's Intraday Session June 06, 2023 Via Benzinga AlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of BK Infection in Kidney Transplant Recipients at the American Transplant Congress (ATC 2023) June 05, 2023 From AlloVir, Inc. Via Business Wire Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 06, 2023 Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. Via Benzinga AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer May 16, 2023 From AlloVir Via Business Wire AlloVir Reports First Quarter 2023 Financial Results May 04, 2023 From AlloVir Via Business Wire AlloVir to Present at the BofA Securities 2023 Health Care Conference May 01, 2023 From AlloVir, Inc. Via Business Wire AlloVir's Posoleucel Achieves Non-Relapse Mortality Of 0% In Transplant Patients For Viral Infections April 26, 2023 AlloVir Inc (NASDAQ: ALVR) announced the presentation of long-term, follow-up data from the Phase 2 study of posoleucel to prevent infections from six viruses in allogeneic hematopoietic cell... Via Benzinga AlloVir Announces Positive Results Including Long-Term Mortality Data in Phase 2 Posoleucel Multi-Virus Prevention Study in Oral Presentation at EBMT 2023 April 26, 2023 From AlloVir, Inc. Via Business Wire Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday April 13, 2023 U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 09, 2023 Via Benzinga AlloVir Appoints Derek Adams, Ph.D., to Board of Directors February 23, 2023 From AlloVir Via Business Wire AlloVir Announces Final Results From Posoleucel Study In Kidney Transplant Recipients With BK Viremia, Shares Fall February 15, 2023 Via Benzinga AlloVir Reports Full-Year 2022 Financial Results and 2023 Outlook February 15, 2023 From AlloVir, Inc. Via Business Wire AlloVir Announces Positive Final Results from Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Posoleucel in Kidney Transplant Recipients with BK Viremia February 15, 2023 From AlloVir, Inc. Via Business Wire AlloVir to Participate in the SVB Securities Global Biopharma Conference February 01, 2023 From AlloVir, Inc. Via Business Wire AlloVir Announces Plans to Complete Enrollment in Three Phase 3 Posoleucel Studies in 2023 January 09, 2023 From AlloVir, Inc. Via Business Wire AlloVir to Present at the 41st Annual J.P. Morgan Healthcare Conference January 03, 2023 From AlloVir, Inc. Via Business Wire AlloVir Announces Positive Final Results in Phase 2 Posoleucel Multi-Virus Prevention Study In Oral Presentation at the 64th ASH Annual Meeting and Exposition December 10, 2022 From AlloVir Via Business Wire AlloVir to Participate in the Piper Sandler 34th Annual Healthcare Conference November 15, 2022 From AlloVir Via Business Wire AlloVir: Q3 Earnings Insights November 03, 2022 AlloVir (NASDAQ:ALVR) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings AlloVir beat estimated earnings by... Via Benzinga Final Data from AlloVir’s Phase 2 Study of Posoleucel for Multi-Virus Prevention to be Highlighted in Oral Presentation at 64th American Society of Hematology Annual Meeting November 03, 2022 From AlloVir, Inc. Via Business Wire AlloVir Reports Third Quarter 2022 Financial Results November 03, 2022 From AlloVir, Inc. Via Business Wire Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday October 21, 2022 Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.